Arkolith/Insider Trading/NBIO/Form 4

Holden Lowell Thomas

CFO, DirectorNascent Biotech Inc. (NBIO) · full profile →Form 4 · filed Apr 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Other(J)215K$0.06$13K9.0M
Mar 9, 2022Other(J)1.1M$0.05$55K8.8M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-22-002016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML